CRISPR/Cas9基因组编辑技术在癌症研究中的应用

doi:10.16288/j.yczz.15-252

遗传 ›› 2016, Vol. 38 ›› Issue (1): 1-8.doi: 10.16288/j.yczz.15-252

• 综述 • 下一篇

CRISPR/Cas9基因组编辑技术在癌症研究中的应用

王大勇^{1, 2, 3}, 马宁^{1, 2, 3}, 惠洋^{1, 2, 3}, 高旭^{1, 2, 3}

1. 哈尔滨医科大学生物化学与分子生物学教研室,哈尔滨 150086;
2. 哈尔滨医科大学北方转化医学研究合作中心,哈尔滨 150086;
3. 黑龙江省医学科学院,哈尔滨 150086

收稿日期:2015-08-31 修回日期:2015-11-20 出版日期:2016-01-20 发布日期:2016-01-20
通讯作者: 高旭,博士,教授,研究方向：遗传改变模式动物的建立及复杂疾病机制研究。E-mail:gaoxu_671227@163.com E-mail:84dayong@163.com
作者简介:王大勇,博士,专业方向：遗传改变模式动物的建立及复杂疾病机制研究。
基金资助:
国家自然基金项目（编号：81270511, 81200827）资助

The application of CRISPR/Cas9 genome editing technology in cancer research

Dayong Wang^{1, 2, 3}, Ning Ma^{1, 2, 3}, Yang Hui^{1, 2, 3}, Xu Gao^{1, 2, 3}

1. Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin 150086, China;
2. Translational Medicine Research and Cooperation Center of Northern China, Harbin Medical University, Harbin 150086, China;
3. Heilongjiang Academy of Medical Sciences, Harbin 150086, China

Received:2015-08-31 Revised:2015-11-20 Online:2016-01-20 Published:2016-01-20
Supported by:
[Supported by the National Natural Science Foundation of China (Nos; 81270511, 81200827)]

摘要/Abstract

摘要： CRISPR/cas9基因组编辑技术因其设计简单以及操作容易,使其在基因编辑的研究中越来越受到欢迎。利用该技术,科研人员可以实现在碱基的水平对基因组进行定点修饰。CRISPR系统现已经被广泛地应用到多个物种的基因组编辑以及癌症的相关研究中。本文在最新研究进展的基础上,结合对癌症研究及基因组编辑技术的理解,对CRISPR/Cas9技术在癌症研究中的应用进行了综述。

关键词: CRISPR, CRISPR/Cas9, 基因编辑, 癌症

Abstract: The CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein-9 nuclease) genome editing technology has become more and more popular in gene editing because of its simple design and easy operation. Using the CRISPR/Cas9 system, researchers can perform site-directed genome modification at the base level. Moreover, it has been widely used in genome editing in multiple species and related cancer research. In this review, we summarize the application of the CRISPR/Cas9 system in cancer research based on the latest research progresses as well as our understanding of cancer research and genome editing techniques.

Key words: CRISPR, CRISPR/Cas9, gene editing, cancer

王大勇, 马宁, 惠洋, 高旭. CRISPR/Cas9基因组编辑技术在癌症研究中的应用[J]. 遗传, 2016, 38(1): 1-8.

Dayong Wang, Ning Ma, Yang Hui, Xu Gao. The application of CRISPR/Cas9 genome editing technology in cancer research[J]. HEREDITAS(Beijing), 2016, 38(1): 1-8.

参考文献

[1] Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol , 1987, 169(12): 5429-5433.
[2] Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science , 2014, 346(6213): 1258096.
[3] Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell , 2014, 157(6): 1262-1278.
[4] Wang HY, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell , 2013, 153(4): 910-918.
[5] Yang H, Wang HY, Shivalila CS, Cheng AW, Shi LY, Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell , 2013, 154(6): 1370-1379.
[6] Zhou XQ, Xin JG, Fan NN, Zou QJ, Huang J, Ouyang Z, Zhao Y, Zhao BT, Liu ZM, Lai SS, Yi XL, Guo L, Esteban MA, Zeng YZ, Yang HQ, Lai LX. Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci , 2015, 72(6): 1175-1184.
[7] Wan HF, Feng CJ, Teng F, Yang SH, Hu BY, Niu YY, Xiang AP, Fang WZ, Ji WZ, Li W, Zhao XY, Zhou Q. One-step generation of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas system. Cell Res , 2015, 25(2): 258-261.
[8] Zhao P, Zhang Z, Ke HM, Yue YR, Xue D. Oligonucleotide-based targeted gene editing in C. elegans via the CRISPR/Cas9 system. Cell Res , 2014, 24(2): 247-250.
[9] Hruscha A, Krawitz P, Rechenberg A, Heinrich V, Hecht J, Haass C, Schmid B. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development , 2013, 140(24): 4982-4987.
[10] Hwang WY, Fu YF, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JRJ, Joung JK. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol , 2013, 31(3): 227-229.
[11] Shan QW, Wang YP, Li J, Zhang Y, Chen KL, Liang Z, Zhang K, Liu JX, Xi JZJ, Qiu JL, Gao CX. Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol , 2013, 31(8): 686-688.
[12] Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature , 2015, 517(7536): 583-588.
[13] Bikard D, Jiang WY, Samai P, Hochschild A, Zhang F, Marraffini LA. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res , 2013, 41(15): 7429-7437.
[14] Liu T, Li YJ, Wang XD, Ye Q, Li H, Liang YX, She QX, Peng N. Transcriptional regulator-mediated activation of adaptation genes triggers CRISPR de novo spacer acquisition. Nucleic Acids Res , 2015, 43(2): 1044-1055.
[15] Zhou JW, Xu QB, Yao J, Yu SM, Cao SZ. CRISPR/Cas9 genome editing technique and its application in site-directed genome modification of animals. Hereditas (Beijing) , 2015, 37(10): 1011-1020. 周金伟, 徐绮嫔, 姚婧, 余树民, 曹随忠. CRISPR/Cas9基因组编辑技术及其在动物基因组定点修饰中的应用. 遗传, 2015, 37(10): 1011-1020.
[16] Kraft K, Geuer S, Will AJ, Chan WL, Paliou C, Borschiwer M, Harabula I, Wittler L, Franke M, Ibrahim DM, Kragesteen BK, Spielmann M, Mundlos S, Lupiáñez DG, Andrey G. Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice. Cell Rep , 2015, 10(5): 833-839, doi:10.1016/ j.celrep. 2015.01.016.
[17] Stell A, Biserni A, Della Torre S, Rando G, Ramachandran B, Ottobrini L, Lucignani G, Maggi A, Ciana P. Cancer modeling: modern imaging applications in the generation of novel animal model systems to study cancer progression and therapy. Int J Biochem Cell Biol , 2007, 39(7-8): 1288-1296.
[18] van Dy

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

CRISPR/Cas9基因组编辑技术在癌症研究中的应用

The application of CRISPR/Cas9 genome editing technology in cancer research

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	卞中, 曹东平, 庄文姝, 张舒玮, 刘巧泉, 张林. 水稻分子设计育种启示：传统与现代相结合[J]. 遗传, 2023, 45(9): 718-740.
[2]	孔维泽, 柳艺石, 高晓冬, 藤田盛久. 数据驱动的人体正常和癌症组织中糖基磷脂酰肌醇锚定蛋白(GPI-AP)相关基因表达谱的综合分析[J]. 遗传, 2023, 45(8): 669-683.
[3]	王秉政, 张超, 张佳丽, 孙锦. 利用单转录本表达Cas9和sgRNA条件性编辑果蝇基因组[J]. 遗传, 2023, 45(7): 593-601.
[4]	刘丹妮, 武海萍, 周国华. 可视化分析在病原体核酸现场快速检测中的研究进展[J]. 遗传, 2023, 45(4): 306-323.
[5]	吴仲胜, 高誉, 杜勇涛, 党颂, 何康敏. CRISPR-Cas9基因编辑技术对细胞内源蛋白进行荧光标记的实验操作[J]. 遗传, 2023, 45(2): 165-175.
[6]	刘梅珍, 王立人, 李咏梅, 马雪云, 韩红辉, 李大力. 利用CRISPR/Cas9技术构建基因编辑大鼠模型[J]. 遗传, 2023, 45(1): 78-87.
[7]	张潇筠, 徐坤, 沈俊岑, 穆璐, 钱泓润, 崔婕妤, 马宝霞, 陈知龙, 张智英, 魏泽辉. 一种新型提高HDR效率的CRISPR/Cas9-Gal4BD供体适配基因编辑系统[J]. 遗传, 2022, 44(8): 708-719.
[8]	张充, 魏子璇, 王敏, 陈瑶生, 何祖勇. 利用CRISPR/Cas9在人类黑色素瘤细胞中编辑MC1R与功能分析[J]. 遗传, 2022, 44(7): 581-590.
[9]	漆思晗, 王棨临, 张俊有, 刘倩, 李春燕. 增强子调控癌症发生发展的机制研究[J]. 遗传, 2022, 44(4): 275-288.
[10]	张杨景晖, 常沛瑶, 杨紫淑, 薛宇航, 李雪奇, 张旸. 表观遗传修饰影响花青苷合成研究进展[J]. 遗传, 2022, 44(12): 1117-1127.
[11]	刘尧, 周先辉, 黄舒泓, 王小龙. 引导编辑：突破碱基编辑类型的新技术[J]. 遗传, 2022, 44(11): 993-1008.
[12]	韩玉婷, 许博文, 李羽童, 卢心怡, 董习之, 邱雨浩, 车沁耘, 朱芮葆, 郑丽, 李孝宸, 司绪, 倪建泉. 模式动物果蝇的基因调控前沿技术[J]. 遗传, 2022, 44(1): 3-14.
[13]	雷常贵, 贾学渊, 孙文靖. 基于癌症基因组图谱计划多组学数据构建胶质母细胞瘤六基因预后模型[J]. 遗传, 2021, 43(7): 665-679.
[14]	王海涛, 李亭亭, 黄勋, 马润林, 刘秋月. 遗传修饰技术在绵羊分子设计育种中的应用[J]. 遗传, 2021, 43(6): 580-600.
[15]	杨光武, 田嫄. 果蝇F-box基因Ppa促进脂肪储存[J]. 遗传, 2021, 43(6): 615-622.